Aurobindo Pharma shares react after USFDA issues observation
USFDA issued one observation after inspecting an API manufacturing facility of Aurobindo Pharma’s wholly owned subsidiary Apitoria Pharma in Gaddapotharam, Telangana. The inspection ran Sept. 7–Sept. 15, and TradingView News says shares will remain in focus on Sept. 16.
Aurobindo Pharma shares will remain in focus on September 16 after the USFDA issued one observation following an inspection of an API manufacturing facility of its wholly owned subsidiary Apitoria Pharma in Gaddapotharam, Telangana.The inspection was conducted from September 7 to September 15 and c…